Vikram Rajagopal
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Bioactive natural compounds 1
-
- Alzheimer's disease research and treatments 2
- Co-authors
- Vijay K. Kalra (3 shared papers)Ranjit K. Giri (2 shared papers)Cage S. Johnson (1 shared paper)Caryn S. Gonsalves (1 shared paper)Shruti Agarwal (1 shared paper)Sudha Singh (1 shared paper)Sandip K. Basu (1 shared paper)Nitin Patel (1 shared paper)
- Journals
- The Journal of Immunology (1 paper)Science Translational Medicine (1 paper)FEBS Journal (1 paper)Journal of Biological Chemistry (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- IndiaUnited States
In The Last Decade
Vikram Rajagopal
9 papers receiving 493 citations
Peers
Comparison fields: 5 of 86
- Molecular Medicine 38
- Cancer Research 75
- Neurology 36
- Immunology 90
- Parasitology 26
Countries citing papers authored by Vikram Rajagopal
This map shows the geographic impact of Vikram Rajagopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Rajagopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Rajagopal more than expected).
Fields of papers citing papers by Vikram Rajagopal
This network shows the impact of papers produced by Vikram Rajagopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Rajagopal. The network helps show where Vikram Rajagopal may publish in the future.
Co-authors
The 21 scholars most cited alongside Vikram Rajagopal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 156 | |
| 2 | 2004 | 106 | |
| 3 | 2004 | 72 | |
| 4 | 2013 | 58 | |
| 5 | 2010 | 38 | |
| 6 | 2011 | 30 | |
| 7 | 2005 | 28 | |
| 8 | 2010 | 11 | |
| 9 | Evaluation of target mRNA cleavage by aurorakinase B specific siRNA in prostate and hepatic cancer cells and its therapeutic potential in mouse models of liver cancer. | 2014 | 6 |
About Vikram Rajagopal
Vikram Rajagopal is a scholar working on Molecular Biology, Physiology, Immunology, Oncology and Epidemiology, having authored 9 papers that have together received 505 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Alzheimer's disease research and treatments (2 papers), Immune Response and Inflammation (2 papers), Research on Leishmaniasis Studies (2 papers), Trypanosoma species research and implications (2 papers), HIV Research and Treatment (1 paper), Bioactive natural compounds (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Molecular Medicine (38 citations), Cancer Research (75 citations), Neurology (36 citations), Immunology (90 citations) and Parasitology (26 citations). Vikram Rajagopal has collaborated with scholars based in India and United States. Frequent co-authors include Vijay K. Kalra, Ranjit K. Giri, Cage S. Johnson, Caryn S. Gonsalves, Shruti Agarwal, Sudha Singh, Sandip K. Basu, Nitin Patel, Gauranga Mukhopadhyay and Amitabha Mukhopadhyay. Their work appears in journals such as The Journal of Immunology, Science Translational Medicine, FEBS Journal, Journal of Biological Chemistry and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.